EPICS Therapeutics

EPICS Therapeutics is a dynamic biotechnology research company dedicated to the discovery and development of innovative small molecule drugs. Focusing on RNA epigenetic mechanisms, EPICS Therapeutics is at the forefront of developing novel clinical agents designed to address critical unmet medical needs in oncology.

Located at 47 Adrienne Bolland, Gosselies, Wallonie 6041, BE, EPICS Therapeutics is committed to meeting high value-added endpoints through rigorous research and development. The company balances risk and reward in its approach to partnering programs, ensuring strategic growth and impactful outcomes in the fight against cancer.

EPICS Therapeutics is rapidly advancing in the biotechnology sector, and more information about their cutting-edge work will be available soon, with the support of the company’s management. We invite the manager of EPICS Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further highlight their contributions to biotechnology research and drug development.